Jenburkt Pharma - Quaterly Results

26 Oct 2021 Evaluate
The revenue zoomed 16.48% to Rs. 355.08 millions for the quarter ended September 2021 as compared to Rs. 304.85 millions during the corresponding quarter last year.An average growth of 40.54% was recorded for the quarter ended September 2021 to Rs. 79.70  millions from Rs. 56.71 millions.Operating profit for the quarter ended September 2021 rose to 114.59 millions as compared to 81.93 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 355.08 304.85 16.48 626.88 479.16 30.83 1092.94 1188.91 -8.07
Other Income 11.91 10.23 16.42 23.86 19.99 19.36 43.08 42.18 2.13
PBIDT 114.59 81.93 39.86 180.14 97.96 83.89 241.52 239.63 0.79
Interest 1.09 1.24 -12.10 2.12 2.36 -10.17 4.74 5.26 -9.89
PBDT 113.50 80.69 40.66 178.02 95.60 86.21 236.78 234.37 1.03
Depreciation 4.54 5.06 -10.28 8.88 10.00 -11.20 20.35 22.99 -11.48
PBT 108.96 75.63 44.07 169.14 85.60 97.59 216.43 211.38 2.39
TAX 29.26 18.92 54.65 42.93 18.81 128.23 51.39 62.68 -18.01
Deferred Tax -0.74 -1.08 -31.48 -1.35 -5.04 -73.21 -3.91 3.69 -205.96
PAT 79.70 56.71 40.54 126.21 66.79 88.97 165.04 148.70 10.99
Equity 45.89 45.89 0.00 45.89 45.89 0.00 45.89 45.89 0.00
PBIDTM(%) 32.27 26.88 20.08 28.74 20.44 40.56 22.10 20.16 9.64

Jenburkt Pharma Share Price

793.00 1.90 (0.24%)
24-May-2024 10:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1488.80
Dr. Reddys Lab 5865.55
Cipla 1488.25
Zydus Lifesciences 1084.55
Lupin 1628.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.